Tiburio Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-08. The offering totals $31.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Christoph M Adams | Director | CAMBRIDGE, MA |
| Sandip Kirstine Agarwala | Director | Cambridge, MA |
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |
| David Kirstine Mott | Director | Cambridge, MA |
| Sara Kirstine Nayeem | Director | Cambridge, MA |
| Christoph M Adams | Executive Officer | CAMBRIDGE, MA |
| Abraham N Ceesay | Executive Officer | Cambridge, MA |
| James G McArthur | Executive Officer | CAMBRIDGE, MA |